Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicin, paclitaxel, cyclophosphamide, Methotrexate, 5 FU, darbepoetin alfa|DRUG: Epirubicin, Cyclophosphamide, Paclitaxel, dabepoetin alfa
Sponsor: German Breast Group
Collaborators: Pharmacia|Amgen|Bristol-Myers Squibb